Oral Abuse Potential Study of Nalbuphine

NCT04018664 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Nalbuphine
Opioid Abuse

Interventions

DRUG: Nalbuphine HCl solution
DRUG: Placebo solution

Sponsor

Trevi Therapeutics

Collaborators

[object Object]